trending Market Intelligence /marketintelligence/en/news-insights/trending/1qF9Y135H15PBnvL5SLHmQ2 content esgSubNav
In This List

BioTime closes $28.8M common stock offering

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


BioTime closes $28.8M common stock offering

BioTime Inc. closed its public offering of 9,615,385 common shares at $2.60 apiece with gross proceeds of about $28.8 million.

The share sale includes 1,442,308 shares sold pursuant to the underwriters exercising their option to buy additional shares.

BioTime intends to use the net proceeds from the offering for general corporate purposes, including, without limitation, to fund clinical trials, research and development activities and for general working capital.

Raymond James & Associates Inc. acted as the sole book-running manager for the offering. Ladenburg Thalmann & Co. Inc., Chardan and LifeSci Capital LLC acted as co-managers. Lake Street Capital Markets acted as a financial adviser for the offering.